Home Procurement NewsJ&J to buy neurological drugmaker Intra-Cellular for $14.6 billion

J&J to buy neurological drugmaker Intra-Cellular for $14.6 billion

January 13, 2025•

Johnson & Johnson said on Monday it would buy drugmaker Intra-Cellular Therapies for $14.6 billion, boosting its market for neurological disorder treatments.

Was this article helpful?

YesNo

Last modified: January 13, 2025

Previous: Contractors to Protest Non-payment by DESOPADEC

Next: LNG exporter Venture Global seeks up to $110 billion valuation in U.S. IPO

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships